EUVIMEDEUVIMED entdecken
Crossref

Harnessing phage-ciprofloxacin synergy to overcome multidrug-resistant infections and biofilm persistence

Nashath Kalangadan, Srivignesh Sundaresan, Abishek Mani, Nandhakumar Muruganandham, Siji Siju, Sutharsan Govindarajan, Kaushik Rajaram iD

Archives of Microbiology · 2026

DOI: 10.1007/s00203-026-05223-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Microbiology, 2026. Verfasst von Nashath Kalangadan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Central University of Tamil Nadu, Thiruvarur, India. Hauptthemen laut MEDLINE: Biofilms, Enterococcus faecalis, Ciprofloxacin, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 94 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enterococcus faecalis is a Gram-positive opportunistic pathogen commonly associated with hospital-acquired and chronic wound infections. Its capacity for biofilm formation and increasing resistance to standard antibiotics, particularly ciprofloxacin (CIP), complicates treatment. The emergence of CIP-resistant E. faecalis (EFR) strains limits existing antibiotic options and requires alternative treatment approaches. Our study evaluated the antibacterial efficacy of a lytic bacteriophage (φR12EFP) and its combination with CIP against E. faecalis. Phage φR12EFP was isolated from environmental samples and characterized. Transmission electron microscopy revealed an icosahedral tailed morphology. Whole-genome sequencing identified a 58.6 kb linear double-stranded DNA genome with high coding density and no lysogeny-associated genes, confirming its classification within the Saphexavirus genus. φR12EFP exhibited host specificity toward E. faecalis. Growth curve analysis showed the emergence of bacterial resistance after 10 h of phage exposure. Adsorption and one-step growth assays demonstrated rapid host attachment, with a burst size of approximately 356 PFU/cell, and optimal antibacterial activity at a multiplicity of infection (MOI) of 0.1. φR12EFP remained stable between 4 and 60 °C and pH 5-9. A CIP-resistant EFR strain was developed under selective pressure to establish a clinically relevant model. Combined treatment with φR12EFP (MOI 0.1) and low-dose CIP (5 µg/mL) exhibited EFR bacterial suppression and restored antibiotic efficacy. The combination reduced established EFR biofilm by 75% and improved embryo survival to 90-100% in an in ovo infection model compared with φR12EFP monotherapy alone. These findings indicate that φR12EFP restores CIP sensitivity in resistant E. faecalis and supports the use of phage-antibiotic regimens against multidrug-resistant enterococci.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsEnterococcus faecalisCiprofloxacinDrug Resistance, Multiple, BacterialBacteriophagesAnti-Bacterial AgentsGenome, ViralHost SpecificityMicrobial Sensitivity Tests

Stichwörter der Autor:innen

In ovo infection controlAntibiofilm activityBacteriophage therapyCombination therapyFractional inhibition concentrationMultiplicity of infection

Substanzen

CiprofloxacinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Central University of Tamil Nadu, Thiruvarur, India.
  • Department of Horticulture, Central University of Tamil Nadu, Thiruvarur, India.
  • Department of Biological Sciences, SRM University-AP, Amaravati, Andhra Pradesh, India.
  • Department of Microbiology, Central University of Tamil Nadu, Thiruvarur, India. rkaushik@cutn.ac.in.

ORCID-Profile: Kaushik Rajaram

Zitieren

APA

Kalangadan, N., Sundaresan, S., Mani, A., Muruganandham, N., Siju, S., Govindarajan, S., & Rajaram, K. (2026). Harnessing phage-ciprofloxacin synergy to overcome multidrug-resistant infections and biofilm persistence. Archives of Microbiology. https://doi.org/10.1007/s00203-026-05223-8

Vancouver

Kalangadan N, Sundaresan S, Mani A, Muruganandham N, Siju S, Govindarajan S, et al. Harnessing phage-ciprofloxacin synergy to overcome multidrug-resistant infections and biofilm persistence. Archives of Microbiology. 2026. doi:10.1007/s00203-026-05223-8

BibTeX
@article{Kalangadan2026,
  author = {Kalangadan, Nashath and Sundaresan, Srivignesh and Mani, Abishek and Muruganandham, Nandhakumar and Siju, Siji and Govindarajan, Sutharsan and Rajaram, Kaushik},
  title = {Harnessing phage-ciprofloxacin synergy to overcome multidrug-resistant infections and biofilm persistence},
  journal = {Archives of Microbiology},
  year = {2026},
  doi = {10.1007/s00203-026-05223-8}
}
Kostenlos starten →